Skip to main content
. 2004 Aug 3;91(6):1032–1037. doi: 10.1038/sj.bjc.6602076

Table 3. Haematologic toxicity.

  Leukopenia
Neutropenia
Anemia
Thrombocytopenia
 
Dose level G1 G2 G3 G4 G1 G2 G3 G4 G1 G2 G3 G1 G2 G3 G4 Grade 3/4 toxicity (%)
Phase I
1 (n=3) 0 0 3 0 0 1 2 0 0 1 1 1 0 0 0 100
2 (n=3) 0 2 1 0 0 2 1 0 1 1 0 0 0 0 0 33
3 (n=2) 0 0 1 1 0 0 0 2 0 0 2 0 0 1 1 100
                                 
Phase II
2 (cycles=50)a 6 19 18 1 9 9 22 6 17 17 10 4 8 4 1 62a
1 (cycles=8) 0 2 5 1 0 1 3 4 1 2 5 1 2 2 1 100
Total (cycles=58) 6 21 23 2 9 10 25 10 18 19 15 5 10 6 2 67
a

Three patients were from the phase I study.